{"id":"https://openalex.org/W2017514657","doi":"https://doi.org/10.1007/s00702-009-0323-9","title":"The dopamine D2 receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with l-dopa","display_name":"The dopamine D2 receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with l-dopa","publication_year":2009,"publication_date":"2009-10-06","ids":{"openalex":"https://openalex.org/W2017514657","doi":"https://doi.org/10.1007/s00702-009-0323-9","mag":"2017514657","pmid":"https://pubmed.ncbi.nlm.nih.gov/19809864"},"language":"en","primary_location":{"id":"doi:10.1007/s00702-009-0323-9","doi":"https://doi.org/10.1007/s00702-009-0323-9","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00702-009-0323-9","pdf_url":null,"source":{"id":"https://openalex.org/S1737980","display_name":"Journal of Neural Transmission","issn_l":"0300-9564","issn":["0300-9564","1435-1463"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neural Transmission","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://ruj.uj.edu.pl/xmlui/handle/item/15288","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Michael John Jackson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael John Jackson","raw_affiliation_strings":["School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King's College, London, SE1 1UL, UK","School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King's College, London, SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051379328","display_name":"Terrance H. Andree","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terrance H. Andree","raw_affiliation_strings":["Discovery Neuroscience (THA) and Chemical and Screening Sciences (GS), Wyeth Research, Princeton, NJ, USA","Discovery Neuroscience (THA) and Chemical and Screening Sciences (GS), Wyeth Research, Princeton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Neuroscience (THA) and Chemical and Screening Sciences (GS), Wyeth Research, Princeton, NJ, USA","institution_ids":["https://openalex.org/I4403928396"]},{"raw_affiliation_string":"Discovery Neuroscience (THA) and Chemical and Screening Sciences (GS), Wyeth Research, Princeton, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009853865","display_name":"Matthew J. Hansard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Matthew Hansard","raw_affiliation_strings":["School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, SE1 1UL, UK","School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113532585","display_name":"Diane C. Hoffman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diane C. Hoffman","raw_affiliation_strings":["Neurogen Corporation, Branford, CT, USA","Neurogen Corporation, Branford, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurogen Corporation, Branford, CT, USA","institution_ids":[]},{"raw_affiliation_string":"Neurogen Corporation, Branford, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048618747","display_name":"Mark R. Hurtt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark R. Hurtt","raw_affiliation_strings":["Neurogen Corporation, Branford, CT, USA","Neurogen Corporation, Branford, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurogen Corporation, Branford, CT, USA","institution_ids":[]},{"raw_affiliation_string":"Neurogen Corporation, Branford, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113517318","display_name":"John H. Kehne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John H. Kehne","raw_affiliation_strings":["Neurogen Corporation, Branford, CT, USA","Neurogen Corporation, Branford, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurogen Corporation, Branford, CT, USA","institution_ids":[]},{"raw_affiliation_string":"Neurogen Corporation, Branford, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085045352","display_name":"Thomas A. Pitler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas A. Pitler","raw_affiliation_strings":["Neurogen Corporation, Branford, CT, USA","Neurogen Corporation, Branford, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurogen Corporation, Branford, CT, USA","institution_ids":[]},{"raw_affiliation_string":"Neurogen Corporation, Branford, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103517453","display_name":"Lance A. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lance A. Smith","raw_affiliation_strings":["School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, SE1 1UL, UK","School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Gary Stack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Stack","raw_affiliation_strings":["Discovery Neuroscience (THA) and Chemical and Screening Sciences (GS), Wyeth Research, Princeton, NJ, USA","Discovery Neuroscience (THA) and Chemical and Screening Sciences (GS), Wyeth Research, Princeton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Neuroscience (THA) and Chemical and Screening Sciences (GS), Wyeth Research, Princeton, NJ, USA","institution_ids":["https://openalex.org/I4403928396"]},{"raw_affiliation_string":"Discovery Neuroscience (THA) and Chemical and Screening Sciences (GS), Wyeth Research, Princeton, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105511214","display_name":"Peter G. Jenner","orcid":"https://orcid.org/0009-0006-0327-7584","observed_orcids":["https://orcid.org/0009-0006-0327-7584"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Peter Jenner","raw_affiliation_strings":["School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, SE1 1UL, UK","School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"School of Health and Biomedical Sciences, Neurodegenerative Diseases Research Centre, King\u2019s College, London, UK","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5105511214"],"corresponding_institution_ids":["https://openalex.org/I183935753"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":1.489,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.82212685,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"117","issue":"1","first_page":"55","last_page":"67"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Neurological disorders and treatments","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-d2-receptor-partial-agonist","display_name":"dopamine D2 receptor partial agonist","score":0.9580000042915344},{"id":"https://openalex.org/keywords/l-dopa","display_name":"L-DOPA","score":0.6970000267028809},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.8180000185966492},{"id":"https://openalex.org/keywords/mptp","display_name":"MPTP","score":0.6990000009536743},{"id":"https://openalex.org/keywords/marmoset","display_name":"marmoset","score":0.6890000104904175},{"id":"https://openalex.org/keywords/dyskinesia","display_name":"dyskinesia","score":0.9039999842643738},{"id":"https://openalex.org/keywords/motor-impairment","display_name":"motor impairment","score":0.8619999885559082},{"id":"https://openalex.org/keywords/locomotor-activity","display_name":"locomotor activity","score":0.8870000243186951},{"id":"https://openalex.org/keywords/carbidopa","display_name":"carbidopa","score":0.8209999799728394},{"id":"https://openalex.org/keywords/dopamine-replacement-therapy","display_name":"dopamine replacement therapy","score":0.7049999833106995},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.45500001311302185}],"concepts":[{"id":"https://openalex.org/C2780405171","wikidata":"https://www.wikidata.org/wiki/Q629444","display_name":"Dyskinesia","level":4,"score":0.8237605094909668},{"id":"https://openalex.org/C2778674702","wikidata":"https://www.wikidata.org/wiki/Q239816","display_name":"MPTP","level":4,"score":0.8007892370223999},{"id":"https://openalex.org/C2776754145","wikidata":"https://www.wikidata.org/wiki/Q71133637","display_name":"Carbidopa","level":5,"score":0.7898551821708679},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6373605728149414},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6174855828285217},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5836191773414612},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.5431148409843445},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.4942636489868164},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.48543840646743774},{"id":"https://openalex.org/C2778258207","wikidata":"https://www.wikidata.org/wiki/Q600203","display_name":"Dopamine agonist","level":4,"score":0.4825277030467987},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.4589551091194153},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43397045135498047},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4244714081287384},{"id":"https://openalex.org/C199596767","wikidata":"https://www.wikidata.org/wiki/Q21110872","display_name":"Dopamine receptor D3","level":4,"score":0.42131906747817993},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.4177935719490051},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.38413530588150024},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3782314360141754},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.32150185108184814},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2926691472530365},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.05628001689910889}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002144","descriptor_name":"Callithrix","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004185","descriptor_name":"Disability Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008124","descriptor_name":"Locomotion","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020267","descriptor_name":"MPTP Poisoning","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020267","descriptor_name":"MPTP Poisoning","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s00702-009-0323-9","doi":"https://doi.org/10.1007/s00702-009-0323-9","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00702-009-0323-9","pdf_url":null,"source":{"id":"https://openalex.org/S1737980","display_name":"Journal of Neural Transmission","issn_l":"0300-9564","issn":["0300-9564","1435-1463"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neural Transmission","raw_type":"journal-article"},{"id":"pmid:19809864","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19809864","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neural transmission (Vienna, Austria : 1996)","raw_type":"Journal Article"},{"id":"pmh:oai:ruj.uj.edu.pl:item/15288","doi":null,"is_oa":true,"landing_page_url":"http://ruj.uj.edu.pl/xmlui/handle/item/15288","pdf_url":"http://ruj.uj.edu.pl/xmlui/handle/item/15288","source":{"id":"https://openalex.org/S4306401249","display_name":"Jagiellonian University Repository (Jagiellonian University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126596746","host_organization_name":"Jagiellonian University","host_organization_lineage":["https://openalex.org/I126596746"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"mag:19809864","doi":null,"is_oa":false,"landing_page_url":"http://www.ejournals.eu/pliki/art/622/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:ruj.uj.edu.pl:item/15288","doi":null,"is_oa":true,"landing_page_url":"http://ruj.uj.edu.pl/xmlui/handle/item/15288","pdf_url":"http://ruj.uj.edu.pl/xmlui/handle/item/15288","source":{"id":"https://openalex.org/S4306401249","display_name":"Jagiellonian University Repository (Jagiellonian University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126596746","host_organization_name":"Jagiellonian University","host_organization_lineage":["https://openalex.org/I126596746"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306430","display_name":"National Parkinson Foundation","ror":"https://ror.org/005aa3k38"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2017514657.pdf","grobid_xml":"https://content.openalex.org/works/W2017514657.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W95961711","https://openalex.org/W1980202815","https://openalex.org/W2002159489","https://openalex.org/W2003534327","https://openalex.org/W2008851901","https://openalex.org/W2010206955","https://openalex.org/W2010464895","https://openalex.org/W2010823249","https://openalex.org/W2012557172","https://openalex.org/W2016947344","https://openalex.org/W2028310069","https://openalex.org/W2038538575","https://openalex.org/W2042638389","https://openalex.org/W2053308850","https://openalex.org/W2054581670","https://openalex.org/W2058003793","https://openalex.org/W2064042412","https://openalex.org/W2076224451","https://openalex.org/W2092066896","https://openalex.org/W2110470644","https://openalex.org/W2115222037","https://openalex.org/W2118740051","https://openalex.org/W2142008956","https://openalex.org/W2147895418","https://openalex.org/W2155040608","https://openalex.org/W2156629529","https://openalex.org/W2322912881","https://openalex.org/W2412365404"],"related_works":["https://openalex.org/W2029405505","https://openalex.org/W1985686554","https://openalex.org/W1531176984","https://openalex.org/W2006895333","https://openalex.org/W2038248270","https://openalex.org/W2041905045","https://openalex.org/W2122472164","https://openalex.org/W2092066896","https://openalex.org/W2009518623","https://openalex.org/W2156629529"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}